Conditions: Alagille Syndrome
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 37
Healthy volunteers: no

Brief summary:
The study is a randomized, double-blind, placebo-controlled study in children with Alagille Syndrome (ALGS). The study will investigate the effects of LUM001, compared to placebo, on pruritus, serum bile acids, liver enzymes, and other biochemical markers in patients with ALGS.

Detailed description:

Arms:
arm 1: LUM001 for oral administration arm 2: Placebo administered orally once each day

Interventions: intervention 1: LUM001 intervention 2: Placebo
Intervention descriptions: intervention 1: LUM001 administered orally intervention 2: Placebo administered orally

Protocol document: